Global characterization of copy number variants in epilepsy patients from whole genome sequencing.
Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number variants (CNVs) studies of epilepsy have used array-based technology and were restricted to the detection of large or exonic events. In contrast, whole-genome sequencing (WGS) has the potential to more...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-04-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5978987?pdf=render |